Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T15:52:03.587Z.
Calculation as of: 2026-10-06T15:52:03.587Z.
Quote observation: 2026-10-06T15:50:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 820e6844a86ebcce87b4cbc727545bf8fd5f2e7882f78b89935f6b0fc3bd738c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Larimar Therapeutics, Inc.
Market Cap
$297.62M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$290.91M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$288.87M
Price/FCF Ratio
N/A
TTM Avg
39.34
3Y Avg
39.34
5Y Avg
39.34
Market Cap
$283.42M
Price/FCF Ratio
N/A
TTM Avg
2.52
3Y Avg
2.52
5Y Avg
2.52
Market Cap
$308.55M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$283.92M
Price/FCF Ratio
N/A
TTM Avg
56.97
3Y Avg
56.97
5Y Avg
56.97
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Larimar Therapeutics, Inc. (LRMR) | $297.62M | N/A | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $303.05M | N/A | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $290.74M | N/A | N/A | N/A | N/A |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $290.91M | N/A | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $288.87M | N/A | 39.34 | 39.34 | 39.34 |
| Indaptus Therapeutics, Inc. (INDP)vs › | $283.42M | N/A | 2.52 | 2.52 | 2.52 |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $308.55M | N/A | N/A | N/A | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $283.92M | N/A | 56.97 | 56.97 | 56.97 |
| Aurora Cannabis Inc. (ACB)vs › | $280.60M | N/A | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE)vs › | $279.16M | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
